跳至主要内容
临床试验/CTRI/2020/10/028381
CTRI/2020/10/028381尚未招募1 期

A Randomized Clinical study to evaluate the efficacy of Bibhitakadi Ghrita Tarpana and Ayastha Triphala with Ghrita as oral intake in the management of Timira w. s. r. to Presbyopia

ational Institute of Ayurveda Jaipur0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • i) Patients willing to participate in this trial through written informed consent
  • ii) Patients who are 35 years of age and from either sex
  • ii) Patients having specific symptoms of prathama and dwitiya patalagata timira.
  • iii) Early to moderate presbyope determined by screening monocular best-corrected distant visual acuity (VA)

排除标准

  • i) Patients with active ocular infection at visit 1 (bacterial, viral or fungal), positive history of an ocular herpetic infection, preauricular lymphadenopathy, or ongoing, active ocular inflammation (eg, moderate to severe blepharitis, allergic conjunctivitis, peripheral ulcerative keratitis, scleritis, uveitis), moderate to severe dry eye in either eye.
  • ii) Patients with clinically significant abnormal lens findings (eg cataract) including early lens changes and/or any evidence of media opacity in either eye
  • iii) Patients having intraocular pressure (IOP) that is less than 5 millimeters of mercury (mmHg) or greater than 22 mmHg in either eye documented at visit 1, or have a prior diagnosis of ocular hypertension or glaucoma or currently being treated with any type of topical IOP lowering (glaucoma) medication at visit 1.
  • iv) Patients who have abnormal findings on dilated fundus exam in either eye on visit 1 or a known history of retinal detachment or clinically significant retinal disease in either eye.

研究者

发起方
ational Institute of Ayurveda Jaipur

相似试验

Role of local Ayurveda therapy along with certain... | 临床试验